Center for Farmer's Safety and Health, Gyeongsang National University Hospital, Jinju, Republic of Korea.
Department of Preventive Medicine and Department of Bio & Medical Big Data, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Aging Clin Exp Res. 2021 Sep;33(9):2471-2477. doi: 10.1007/s40520-020-01766-y. Epub 2021 Jan 17.
The purpose of this study was to evaluate the association between sarcopenia and extracellular water-to-total body water ratio (ECW/TBW), one of the results of bioimpedance that can be easily measured in communities, following the recent revision of the Asian Working Group for Sarcopenia.
This study data were extracted from the baseline data of Namgaram-2. Among the surveyed subjects, 885 persons aged 60 years or older were selected as study subjects. All surveys were conducted on a one-on-one interview basis; blood tests, physical function evaluations (hand grip strength, short physical performance battery; SPPB), and dual-energy X-ray absorptiometry (DEXA) and bioimpedance were also conducted. The Asian Working Group's revised definition of sarcopenia was applied. ECW/TBW was one of the results of bioimpedance this study.
A high ECW/TBW was 1.63 times higher in the low grip strength group than in the robust group (P = 0.017) and was 2.13 times higher in the low SPPB group compared to the robust group (P < 0.001). ECW/TBW higher than 0.391 was 2.17 times more likely to occur in sarcopenic patients compared to the robust group (P < 0.001). In addition, ECW/TBW lower than 0.391 was 3.65 times more likely to occur in severely sarcopenic patients compared to the robust group (P = 0.002).
The ECW/TBW may be one of the valid research tools to evaluate the strength and physical performance of the elderly. In addition, it is expected to be one of the effective indicators for tracking physical function under newly revised sarcopenia criteria.
本研究旨在评估肌少症与细胞外液/总体水比值(ECW/TBW)之间的关系,ECW/TBW 是生物电阻抗的结果之一,在社区中易于测量,这是亚洲肌少症工作组最近修订的标准。
本研究数据来自 Namgaram-2 的基线数据。在所调查的对象中,选择了 885 名年龄在 60 岁或以上的人作为研究对象。所有调查均以一对一访谈的形式进行;同时还进行了血液检查、身体功能评估(握力、简短身体机能测试;SPPB)以及双能 X 射线吸收法(DEXA)和生物电阻抗检查。应用亚洲肌少症工作组修订的肌少症定义。ECW/TBW 是本研究中生物电阻抗的结果之一。
握力低的组中,高 ECW/TBW 比强壮组高 1.63 倍(P=0.017),SPPB 低的组比强壮组高 2.13 倍(P<0.001)。ECW/TBW 高于 0.391 的肌少症患者比强壮组发生的可能性高 2.17 倍(P<0.001)。此外,ECW/TBW 低于 0.391 的严重肌少症患者比强壮组发生的可能性高 3.65 倍(P=0.002)。
ECW/TBW 可能是评估老年人力量和身体表现的有效研究工具之一。此外,它有望成为根据新修订的肌少症标准跟踪身体功能的有效指标之一。